Evidence map›Paper›PMID 18703458›Full record

ArticleAmerican journal of public health2009

Preventing mother-to-child transmission of HIV in resource-limited settings: the Elizabeth Glaser Pediatric AIDS Foundation experience.

Allison Spensley, Tabitha Sripipatana, Abigail Norris Turner, Chuck Hoblitzelle, Joanna Robinson, Catherine Wilfert, Elizabeth Glaser Pediatric AIDS Foundation Prevention of Mother-to-Child Transmission of HIV Group

Abstract read
In one paragraph

Article in American journal of public health, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Optimal time on HAART for prevention of mother-to-child transmission of HIV.Journal of acquired immune deficiency syndromes (1999) · 2011
    Article
  16. Immune status at presentation for HIV clinical care in Rio de Janeiro and Baltimore.Journal of acquired immune deficiency syndromes (1999) · 2011
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Allison SpensleyElizabeth Glaser Pediatric AIDS Foundation, Santa Monica, CA, USA. allison@pedaids.org
Tabitha Sripipatana
Abigail Norris Turner
Chuck Hoblitzelle
Joanna Robinson
Catherine Wilfert
Elizabeth Glaser Pediatric AIDS Foundation Prevention of Mother-to-Child Transmission of HIV Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIn September 1999, the Elizabeth Glaser Pediatric AIDS Foundation initiated a multicountry, service-based programmatic effort in the developing world to reduce perinatally acquired HIV infection. We review 6(1/2) years of one of the world's largest programs for the prevention of mother-to-child transmission (PMTCT) of HIV.

methodsEach PMTCT facility records patient data in antenatal clinics and labor and delivery settings about counseling, testing, HIV status, and antiretroviral prophylaxis and submits the data to foundation staff.

resultsMore than 2.6 million women have accessed foundation-affiliated services through June 2006. Overall, 92.9% of women who received antenatal care or were eligible for PMTCT services in labor and delivery have been counseled, and 82.8% of those counseled accepted testing. Among women identified as HIV positive, 75.0% received antiretroviral prophylaxis (most a single dose of nevirapine), as did 45.6% of their infants.

conclusionsThe foundation's experience has demonstrated that opt-out testing, supplying mothers with medication at time of diagnosis, and providing the infant dose early have measurably improved program efficiency. PMTCT should be viewed as an achievable paradigm and an essential part of the continuum of care.

Indexed as

Pregnancy Complications, InfectiousAnti-HIV AgentsCounselingDeveloping CountriesFemaleFoundationsHealth EducationHIV InfectionsHumansInfant, NewbornInfectious Disease Transmission, VerticalNevirapinePregnancyPrenatal CarePrimary PreventionProgram EvaluationAnti-HIV AgentsNevirapine

Identifiers

PMID18703458
PMCPMC2661479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.